Chemoinformaics analysis of 12-cis-octadecadienoate
| Molecular Weight | 371.565 | nRot | 16 |
| Heavy Atom Molecular Weight | 334.269 | nRig | 9 |
| Exact Molecular Weight | 371.282 | nRing | 1 |
| Solubility: LogS | -5.054 | nHRing | 1 |
| Solubility: LogP | 7.121 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 37 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 67.4553 |
| nHD | 0 | BPOL | 40.8627 |
| QED | 0.179 |
| Synth | 2.419 |
| Natural Product Likeliness | 0.297 |
| NR-PPAR-gamma | 0.023 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.16 |
| Pgp-sub | 0.006 |
| HIA | 0.003 |
| CACO-2 | -4.92 |
| MDCK | 0.0000173 |
| BBB | 0.537 |
| PPB | 0.972116 |
| VDSS | 1.809 |
| FU | 0.0149127 |
| CYP1A2-inh | 0.879 |
| CYP1A2-sub | 0.18 |
| CYP2c19-inh | 0.783 |
| CYP2c19-sub | 0.204 |
| CYP2c9-inh | 0.596 |
| CYP2c9-sub | 0.911 |
| CYP2d6-inh | 0.883 |
| CYP2d6-sub | 0.145 |
| CYP3a4-inh | 0.974 |
| CYP3a4-sub | 0.349 |
| CL | 6.286 |
| T12 | 0.586 |
| hERG | 0.825 |
| Ames | 0.011 |
| ROA | 0.432 |
| SkinSen | 0.987 |
| Carcinogencity | 0.079 |
| EI | 0.289 |
| Respiratory | 0.969 |
| NR-Aromatase | 0.952 |
| Antiviral | Yes |
| Prediction | 0.651234 |